Abstract: Systems and methods for generating and providing a virtual walkthrough interface can include generating a virtual walkthrough video based on view synthesis renderings generated by neural radiance field model. The neural radiance field model can be trained based on a plurality of images of an environment and may generate the view synthesis renderings based on processing positions along a determined walkthrough path. The generated virtual walkthrough video can then be scrubbed through to provide the virtual walkthrough interface.

Abstract: The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: or a pharmaceutically acceptable salt thereof.

Abstract: Methods and apparatuses to generate various graphic features, such as fur and hair by modeling features using non-linear contours and positioning a number of intermediate shells to achieve a realistic appearance. These enhancements result in reduced processing time. The intermediate shells may be generated by interpolation of the base and final shells. These processes may be used to build a variety of features, and are particularly suited for grass, hair, fur and so forth.

Abstract: The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, and generalized anxiety disorder.

Abstract: The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, and generalized anxiety disorder.

Abstract: The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.

Abstract: Apparatus which axially stirs solid and/or liquid and/or gaseous substances jointly or individually, characterized by the use of a linear motor or linear servo motor, which enables to select the amplitude, frequency, acceleration, application time of said movement and selection of stirring and rest cycles. The stirring produced by this apparatus can be applied for mixing and/or homogenizing substances and/or extracting the constituent elements of the stirred substances.

Abstract: The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.

Abstract: The invention relates to a system for accelerating moving bodies. The inventive system is characterised in that it comprises the simultaneous application of two torques which are perpendicular to one another and which are perpendicular to the induced or intrinsic angular momentum of the device.

Abstract: Apparatus which axially stirs solid and/or liquid and/or gaseous substances jointly or individually, characterized by the use of a linear motor or linear servo motor, which enables to select the amplitude, frequency, acceleration, application time of said movement and selection of stirring and rest cycles. The stirring produced by this apparatus can be applied for mixing and/or homogenizing substances and/or extracting the constituent elements of the stirred substances.

Abstract: The invention relates to a fluid filter system which can be used to separate the different substances forming said fluid. The invention is characterized in that it comprises the application of a uniform magnetic or electric field in order to produce a Stark effect and the subsequent application of an electric field oscillating in resonance with the energy separation caused by the Stark effect or by a magnetic field oscillating in resonance with the energy separation caused by the Zeeman effect. The molecules involved in the resonation are captured in the filter and subsequently removed using a suction system.

Abstract: The present invention provides kinase inhibitors of Formula I:

Abstract: The present invention provides kinase inhibitors of Formula I: wherein W represents inter alia imidazol, oxazol, pyrazol, thiazol as triazol, which are substituted by phenyl or thienyl.

Abstract: Techniques for automatic dependency resolution are provided. A source machine and a previously successful modification for a given resource, which was modified on the source machine, are identified. Dependencies associated with the modification are identified on the source machine. One or more target machines are selected in response to having a similar profile to that of the source machine. The dependencies are automatically resolved on the target machines and the modification is automatically processed on the target machines to modify the given resource.

Abstract: Techniques for autonomous policy discovery are provided. Machines have personality profiles. The personality profiles permit machines to request advice from different machines having similar personality profiles. This facilitates automatic and autonomous discovery of policies for detected events and facilitates autonomous processing of actions, which are processed in response to the discovered policies. Furthermore, the personality profiles allow administrators to monitor and to dynamically alter policies associated with the machines.

Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.